Greenlight Biosciences Holdings Pbc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2023 to a ratio of 4.14, this represents a new company high. This is a clear indication for improving liquidity at Greenlight Biosciences Holdings Pbc's clients. Average receivable collection period, for the Greenlight Biosciences Holdings Pbc in Mar 31 2023 quarter, has decreased to 88 days, compared to 202 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 502 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 3209 to 3225.

What is Receivable Turnover Ratio?
What is Greenlight Biosciences Holdings Pbc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GRNA Receivables Turnover Ratio	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	1386.38 %	628.43 %	68.65 %	-	-20.92 %
Receivable Turnover Ratio (TTM)	4.14	1.81	1.11	0.92	-
GRNA's Total Ranking	# 3225	# 3209	# 3530	# 3524	# 3975
Accounts Receivable average collection period days	88	202	328	395	-
Seq. Receivable Change	-	-	-	100 %	-
Seq. Revenue Change	26.36 %	74.54 %	-2.04 %	587.94 %	-38.07 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 52
Healthcare Sector	# 503
Overall Market	# 3225

Receivable Turnover Ratio Statistics
High	Average	Low
4.14	1.77	0.21
(Mar 31 2023)		(Mar 31 2022)

GRNA Company Profile • Back to GRNA Efficiency Comparisons • Compare GRNA Receivables Turnover Ratio to its Competitors

Financial Statements
Greenlight Biosciences Holdings Pbc's Accounts Receivable	$ 0 Millions	Visit GRNA's Balance sheet
Greenlight Biosciences Holdings Pbc's Sales TTM	$ 10 Millions	Visit GRNA's Income Statement
Sources of GRNA's Revenues		Visit GRNA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GRNA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GRNA's Growth Rates	GRNA's Roa	GRNA's Inventory Turnover Ratio	GRNA's Dividend Comparisons
GRNA's Profitability Ratios	GRNA's Roi	GRNA's Asset Turnover Ratio	GRNA's Dividend Growth
GRNA's Valuation Ratios	GRNA's Roe	GRNA's Financial Strength Ratios	GRNA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Mar 31 2023

Receivable at quarter ending Mar 31 2023

Date modified: 2026-09-08T15:10:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.